Valeriano, Jeric A.

HRN: 20-74-13  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2023
COTRIMOXAZOLE 960MG (TAB)
10/25/2023
10/31/2023
PO
960
OD
Immunocompromised State; Prophylaxis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Febrile NeutropeniaProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: